Pharma News

The European Commission (EC) has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsychotic Rxulti (brexpiprazole) for schizophrenia in adolescents aged 13 years and a...

Lundbeck has gained orphan drug designation (ODD) from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system atrophy (MSA).

Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company specialising in immunotherapy and targeted oncology treatments, for an aggregate upfront price of $355m.

Raanana, Israel, -- Polyrizon Ltd., a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced the initiation of preclinical studies for intranas...

The Roche Genentech Innovation Center Boston has been launched at Harvard’s Enterprise Research Campus in Allston, MA.

India currently levies around 10 per cent import duty on American drugs, while the US doesn't charge any import duty on Indian drugs.

The UK’s National Institute for Health and Care Excellence (NICE) has issued further draft guidance reaffirming its decision not to recommend the Alzheimer’s treatments Kisunla (donane...

The FDA approved an expanded indication for furosemide injection (Furoscix; scPharmaceuticals, Inc.)

The company previously announced data from another Phase III trial of cebranopadol (developmental code GRT-6005), which also met its primary endpoint.

Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting

Ascentage Pharma said that its drug Olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, and has been approved for certain chronic myeloid leukemia (CML) indications ...

CERo Therapeutics Holdings, Inc. announced that it will present preclinical data for its lead compound, CER-1236, targeting ovarian cancer during the Spring Scientific meeting of the Society for Immun...